Urology · Lubbock, TX
NPI
1437152030
Since 2005
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
6102 82nd St, Suite 5
Lubbock, TX, 79424
Phone (806) 771-0077
Groups this clinician bills Medicare through
Medicare paid, 2024
$545K
14,929 services
Medicare patients, 2024
1,405
Average age 75
Drug cost, 2024
$689K
8,752 prescriptions
Company payments, 2025
$904
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Howard W Beck was code 81003 (clinical chemistry), 1,773 times for 1,124 patients. In total Howard W Beck billed 14,929 services in 108 codes, and Medicare paid $545K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 81003 Clinical Chemistry | Office | 1,773 | 1,124 | $2.20 | $3,894 |
| 87798 Infectious Agent Detection by DNA/RNA | Office | 1,341 | 113 | $34.39 | $46K |
| 36415 Venipuncture Blood Collection | Office | 1,072 | 802 | $8.63 | $9,248 |
| 99214 Office E&M - Established | Office | 887 | 666 | $80.97 | $72K |
| 84153 Clinical Chemistry | Office | 821 | 682 | $17.93 | $15K |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 782 | 148 | $0.36 | $278 |
| 99213 Office E&M - Established | Office | 737 | 619 | $57.18 | $42K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 594 | 539 | $12.26 | $7,282 |
| 76775 Ultrasound - Abdomen and Pelvis | Office | 450 | 388 | $41.30 | $19K |
| 51798 Ultrasound - Nonspecific | Office | 357 | 309 | $7.48 | $2,669 |
| 80053 Clinical Chemistry | Office | 284 | 205 | $10.35 | $2,939 |
| 85025 Blood Count | Office | 200 | 146 | $7.57 | $1,514 |
| J1580 Injection, garamycin, gentamicin, up to 80 mg | Office | 199 | 158 | $1.99 | $397 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 194 | 194 | $48.33 | $9,376 |
| 74018 Standard X-ray | Office | 192 | 133 | $21.10 | $4,052 |
By year: 2022 $521K for 11,012 services; 2023 $568K for 16,776 services; 2024 $545K for 14,929 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 1,773 | 1,124 | $2.20 | $3,894 |
| 87798 Infectious Agent Detection by DNA/RNA | 1,341 | 113 | $34.39 | $46K |
| 36415 Venipuncture Blood Collection | 1,072 | 802 | $8.63 | $9,248 |
| 84153 Clinical Chemistry | 821 | 682 | $17.93 | $15K |
| 80053 Clinical Chemistry | 284 | 205 | $10.35 | $2,939 |
| 85025 Blood Count | 200 | 146 | $7.57 | $1,514 |
| 87481 Infectious Agent Detection by DNA/RNA | 174 | 84 | $34.39 | $5,984 |
| 84154 Clinical Chemistry | 137 | 104 | $17.79 | $2,437 |
| 87500 Infectious Agent Detection by DNA/RNA | 117 | 113 | $34.39 | $4,024 |
| 87641 Infectious Agent Detection by DNA/RNA | 117 | 113 | $34.39 | $4,024 |
Medicare prescription drug claims, 2024
In 2024, the drug Howard W Beck prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,651 prescriptions and refills. In total Howard W Beck wrote 8,752 Medicare prescriptions that cost $689K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,651 | 4,466 | 500 | $32K |
| Finasteride Generic | 1,170 | 3,209 | 343 | $16K |
| Dutasteride Generic | 471 | 1,287 | 150 | $16K |
| Doxycycline Hyclate Generic | 406 | 769 | 218 | $11K |
| Ciprofloxacin Hcl Generic | 403 | 446 | 240 | $4,861 |
| Trimethoprim Generic | 392 | 804 | 129 | $30K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 358 | 1,008 | 118 | $8,825 |
| Potassium Citrate Er Potassium Citrate | 335 | 765 | 96 | $18K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 308 | 733 | 111 | $6,280 |
| Myrbetriq Mirabegron | 306 | 561 | 89 | $245K |
| Doxycycline Monohydrate Generic | 236 | 404 | 76 | $7,591 |
| Oxybutynin Chloride Generic | 188 | 352 | 109 | $2,872 |
| Allopurinol Generic | 146 | 416 | 46 | $2,007 |
| Bethanechol Chloride Generic | 139 | 265 | 46 | $5,634 |
| Tramadol Hcl Generic | 139 | 139 | 123 | $436 |
Brand drugs: 795 claims; generic drugs: 7,925 claims; opioid claims: 172.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Howard W Beck $904 ($904 in general payments such as food, travel and fees) from 15 companies. The largest payer was Boston Scientific Corporation with $184.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 3 | $184 |
| Sumitomo Pharma America, Inc. 4506.T | 7 | $172 |
| Janssen Biotech, Inc. JNJ | 1 | $103 |
| Cycle Pharmaceuticals Inc | 2 | $78.47 |
| Ferring Pharmaceuticals Inc. | 4 | $76.8 |
| Abbvie Inc. ABBV | 3 | $52.56 |
| Pacira Pharmaceuticals Incorporated PCRX | 1 | $41.14 |
| Urogen Pharma, Inc. URGN | 2 | $37.55 |
| Verity Pharmaceuticals Inc. | 2 | $35.35 |
| CIVCO Medical Instruments | 1 | $27.84 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.